REVIEW
Published on 31 Jul 2025
Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma
doi 10.3389/fimmu.2025.1541213
- 1,283 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Streamlining Drug Approvals: Addressing Policy Challenges in Genitourinary Oncology
Streamlining Drug Approvals: Addressing Policy Challenges in Genitourinary Oncology
2,817
Total downloads
12k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 28 Jul 2025
Cost-effectiveness of chemotherapy for advanced and recurrent cervical cancer: a systematic review
doi 10.3389/frhs.2025.1616223
- 2,117 views
REVIEW
Published on 25 Jun 2025
Changing landscape of first-line treatment for locally advanced or metastatic urothelial carcinoma: the progression from platinum-based chemotherapy to platinum-free therapy
doi 10.3389/fimmu.2025.1604395
- 2,818 views
ORIGINAL RESEARCH
Published on 09 Sep 2024
Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States
doi 10.3389/fimmu.2024.1464092
- 3,916 views
- 9 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Health Services
- 2.7 impact factor
- 2.5 citescore
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore